AI assistant
Sending…
MiNK Therapeutics, Inc. — Director's Dealing 2021
Oct 21, 2021
34471_dirs_2021-10-20_0d239b4d-ae49-496c-9ff4-60ed2275afcc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: MiNK Therapeutics, Inc. (INKT)
CIK: 0001840229
Period of Report: 2021-10-13
Reporting Person: FLAMENBAUM WALTER MD (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $0.01 | 2029-11-14 | Common Stock (166980) | Direct | |
| Stock Option (Right to Buy) | $0.01 | 2030-01-30 | Common Stock (139150) | Direct | |
| Stock Option (Right to Buy) | $3.03 | 2031-02-11 | Common Stock (41745) | Direct |
Footnotes
F1: The vesting of all such options was accelerated on March 31, 2021 and were fully-vested as of such date.
More from MiNK Therapeutics, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 23
Interim / Quarterly Report
2026
May 15
Call Transcript
2026
May 15
Earnings Release
2026
May 15
Annual Report
2026
Mar 31
Call Transcript
2026
Mar 31
Earnings Release
2026
Mar 31
Regulatory Filings
2026
Mar 27
Board/Management Information
2026
Mar 19
Director's Dealing
2026
Mar 4